Alnylam Pharmaceuticals (ALNY) Return on Capital Employed Growth (5y) (2015 - 2026)
Alnylam Pharmaceuticals (ALNY) Return on Capital Employed Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,870.00 |
| Dec 31, 2025 | 4,446.00 |
| Sep 30, 2025 | 4,099.00 |
| Jun 30, 2025 | 3,197.00 |
| Mar 31, 2025 | 4,441.00 |
| Dec 31, 2024 | 3,858.00 |
| Sep 30, 2024 | 3,134.00 |
| Jun 30, 2024 | 4,778.00 |
| Mar 31, 2024 | 4,594.00 |
| Dec 31, 2023 | 4,651.00 |
| Sep 30, 2023 | 3,277.00 |
| Jun 30, 2023 | 349.00 |
| Mar 31, 2023 | 115.00 |
| Dec 31, 2022 | 433.00 |
| Sep 30, 2022 | 641.00 |
| Jun 30, 2022 | 1,198.00 |
| Mar 31, 2022 | 1,537.00 |
| Dec 31, 2021 | 1,196.00 |
| Sep 30, 2021 | 714.00 |
| Jun 30, 2021 | 260.00 |